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IMPORTANCE Convolutional neural networks (CNNs) achieve expert-level accuracy in the
diagnosis of pigmentedmelanocytic lesions. However, the most common types of skin cancer
are nonpigmented and nonmelanocytic, and are more difficult to diagnose.
OBJECTIVE To compare the accuracy of a CNN-based classifier with that of physicians with
different levels of experience.
DESIGN, SETTING, AND PARTICIPANTS A CNN-based classificationmodel was trained on 7895
dermoscopic and 5829 close-up images of lesions excised at a primary skin cancer clinic
between January 1, 2008, and July 13, 2017, for a combined evaluation of both imaging
methods. The combined CNN (cCNN) was tested on a set of 2072 unknown cases and
compared with results from 95 human raters who weremedical personnel, including 62
board-certified dermatologists, with different experience in dermoscopy.
MAIN OUTCOMES ANDMEASURES The proportions of correct specific diagnoses and the
accuracy to differentiate between benign andmalignant lesions measured as an area under
the receiver operating characteristic curve served as main outcomemeasures.
RESULTS Among 95 human raters (51.6% female; mean age, 43.4 years; 95% CI, 41.0-45.7
years), the participants were divided into 3 groups (according to years of experience with
dermoscopy): beginner raters (<3 years), intermediate raters (3-10 years), or expert raters
(>10 years). The area under the receiver operating characteristic curve of the trained cCNN
was higher than human ratings (0.742; 95% CI, 0.729-0.755 vs 0.695; 95% CI, 0.676-0.713;
P < .001). The specificity was fixed at themean level of human raters (51.3%), and therefore
the sensitivity of the cCNN (80.5%; 95% CI, 79.0%-82.1%) was higher than that of human
raters (77.6%; 95% CI, 74.7%-80.5%). The cCNN achieved a higher percentage of correct
specific diagnoses compared with human raters (37.6%; 95% CI, 36.6%-38.4% vs 33.5%;
95% CI, 31.5%-35.6%; P = .001) but not compared with experts (37.3%; 95% CI,
35.7%-38.8% vs 40.0%; 95% CI, 37.0%-43.0%; P = .18).
CONCLUSIONS AND RELEVANCE Neural networks are able to classify dermoscopic
and close-up images of nonpigmented lesions as accurately as human experts in an
experimental setting.
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I n comparison with inspection with the unaided eye,dermoscopy (dermatoscopy1) improves the accuracy ofthe diagnosis of pigmented skin lesions.2 The improve-
mentofdermoscopy ismost evident for small and inconspicu-
ous melanomas3 and for pigmented basal cell carcinoma.4
Because dermoscopic criteria are more specific and the
number of differential diagnoses is significantly lower, pig-
mented skin lesions are easier to diagnose than nonpig-
mented lesions.Themost commontypesof skincancers,how-
ever, areusuallynonpigmented.Aprevious studyshowed that
dermoscopy also improves the accuracy of the diagnosis of
nonpigmented lesions, although the improvement was less
pronounced than for pigmented lesions.5 The proportion of
correct diagnoses by expert raters increased from 41.3%with
the unaided eye to 52.7% with dermoscopy. The improve-
ment of nonexperts was less pronounced.
Artificial neural networks have been used for automated
classification of skin lesions for many years6-8 and have also
been tested prospectively.9 In comparison with the neural
networks that were used before 2012,7,10 current convolu-
tional neural networks (CNNs) consist of convolutional fil-
ters, which are able to detect low-level structures such as
colors, contrasts, and edges. These filters allow the CNNs to
be trained “end-to-end,” which means that they need only
raw image data as input without any preprocessing, such as
segmentation or handcrafted feature extraction. Unlike
classical artificial neural networks, which have neurons that
are fully connected to all neurons at the next layer, CNNs
use reusable filters that dramatically simplify the network
connections, which makes them more suitable for image
classification tasks. After Krizhevsky et al11 demonstrated in
2012 that CNNs can be trained on 1.2 million images12 to
classify 1000 categories with high accuracy, CNNs were
increasingly applied to medical images. Convolutional neu-
ral networks have shown expert-level performance in the
classification of skin diseases on clinical images13,14 and in
the classification of pigmented lesions on dermoscopic
images.15-18 Other research groups have combined clinical
and dermoscopic image analysis19,20 or integrated patient
metadata21,22 to improve the performance of CNNs on pig-
mented lesions.
The differentiation of melanoma from benign pig-
mented lesions is a simple binary classification problem.
Performing a differential diagnosis of nonpigmented
lesions, however, is a more complex, multiclass classifica-
tion problem14,15,19 that includes a range of different diag-
nostic categories, such as benign and malignant neoplasms,
cysts, and inflammatory diseases. Automated classifiers
have been applied successfully to clinical images to diag-
nose nonpigmented skin cancer,23 and CNNs trained on
clinical images have recently shown promising results when
compared with physicians’ diagnoses.13,14 Because the per-
formance of CNNs on dermoscopic images of nonpigmented
skin lesions is still unknown, we trained and tested a CNN
on a large set of nonpigmented lesions with a wide range of
diagnoses and compared the results with the accuracy of
human raters with different levels of experience, including
62 board-certified dermatologists.
Methods
Image Data Sets
The 7895dermoscopic and 5829 close-up images of the train-
ing set originated fromaconsecutive sample of lesionsphoto-
graphed and excised by one of us (C.R.) at a primary skin can-
cer clinic in Queensland, Australia, between January 1, 2008,
and July 13, 2017. The 340 dermoscopic and 635 close-up im-
agesof thevalidationsetwereextractedfromeducationalslides
andarepart of a convenience sample of lesionsphotographed
and excised in the practice of one of us (H.S.R). Dermoscopic
images and clinical close-up imageswere takenwithdifferent
cameras and dermatoscopes at different resolutions in polar-
izingornonpolarizingmode.Pathologicdiagnosesweremerged
to correspond to the categoriesused in the studybySinz et al.5
Useof the images is basedonethics reviewboardprotocolsEK
1081/2015 (Medical University of Vienna) and 2015000162
(University of Queensland). Rater data from the survey were
collected in a deidentified fashion; therefore written consent
was not required by the ethics review board of the Medical
University of Vienna.
We included cases that fulfilled the following criteria:
(1) lack of pigment, (2) availability of at least 1 clinical close-up
image or 1 dermatoscopic image, and (3) availability of an
unequivocalhistopathologicreport.Weexcludedmucosalcases,
caseswithmissing or equivocal histopathologic reports, cases
with low imagequality, andcasesofdiagnostic categorieswith
fewer than 10 examples in the training set. All imageswere re-
viewedmanually by 2 of us (H.K. and C.S.) and were included
only if they conformed to the imaging standards published
previously.24 Close-up images were taken with a spacer at-
tached to a digital single-lens reflex camera removing all inci-
dent light and standardizingdistance and field of view. Thedi-
agnostic categoriesused for trainingwere the following: actinic
keratoses and intraepithelial carcinoma (also knownasBowen
disease), basal cell carcinoma (all subtypes), benign keratosis-
like lesions (including solar lentigo, seborrheic keratosis, and
lichen planus–like keratosis), dermatofibroma, melanoma,
invasive squamous cell carcinoma and keratoacanthoma, be-
nign sebaceous neoplasms, and benign hair follicle tumors.
TheTableshowsthefrequenciesofdiagnoses inthetrainingand
validationset.Thetestset imagesof2072dermoscopicandclini-
cal close-up images originated frommultiple sources, includ-
ing theMedical University of Vienna, the image database from
Key Points
Question Can a neural network classify nonpigmented skin
lesions as accurately as human experts?
Findings In this study, a combined convolutional neural network
that received dermoscopic and close-up images as inputs
achieved a diagnostic accuracy on par with human experts and
outperformed beginner raters and intermediate raters.
Meaning In an experimental setting, a combined convolutional
neural network can outperform human raters, but the lack of
accuracy for rare diseases limits its application in clinical practice.
Research Original Investigation Expert-Level Diagnosis of Nonpigmented Skin Cancer by Combined Convolutional Neural Networks
E2 JAMADermatology Published online November 28, 2018 (Reprinted) jamadermatology.com
© 2018 American Medical Association. All rights reserved.
Downloaded From:  by a UZH Hauptbibliothek / Zentralbibliothek Zuerich User  on 12/28/2018
C.R., and a convenience sample of rare diagnoses. The specific
compositionof thetest sethasalreadybeendescribed ingreater
detail by Sinz et al.5 The list of diagnoses of the test set is avail-
able in eTable 1 in the Supplement.
Neural Network Diagnoses
Theoutputofour trainedneuralnetworks representsprobabil-
ity values between 0 and 1 for every diagnostic category.
Wecombined theoutputsof 2CNNs (eAppendix in theSupple-
ment), one trained with dermoscopic images and the other
with clinical close-ups, by extreme gradient boosting
(XGBoost25)ofthecombinedprobabilities.Thiscombinedmodel
is referred toascCNN.For specificdiagnoses,weused thehigh-
est combined class probability and summed the probabilities
of malignant and benign categories to generate receiver oper-
ating characteristic curves. In the validation set, we fixed the
specificityat the levelof theaveragehumanrater (51.3%),which
corresponded to a combinedmalignant class probability of0.2
(eFigure in the Supplement).
Human Ratings
The specifics of the rater study have been described in detail
by Sinz et al.5 In aweb-based study of 95 human raters (51.6%
female;meanage, 43.4years; 95%CI, 41.0-45.7years), partici-
pants were divided into 3 groups (according to years of expe-
riencewith dermoscopy): beginner raters (<3 years), interme-
diate raters (3-10years), orexpert raters (>10years).Dataon the
formal education of the rates are shown in eTable 2 in the
Supplement. All participants rated 50 cases drawn randomly
fromtheentire test setof2072nonpigmented lesions.The ran-
domsamplewas stratified according todiagnostic category to
prevent overrepresentation of commondiagnoses. The raters
were asked to differentiate between benign and malignant
lesions, tomake a specific diagnosis, and to suggest therapeu-
ticmanagement.Theclinical close-up imagewasalwaysshown
before thedermatoscopic image, and the final evaluationwas
based on the combination of both imagingmodalities.
Statistical Analysis
Statistical calculationsandvisualizationswereperformedwith
RStatistics.26The50randomlydrawnratingsofeachraterwere
comparedwith thecCNNoutput for thesame50cases inapair-
wise fashionusingpaired t tests.Receiveroperating character-
istic curves were calculated by pooling all rating sets to allow
comparabilitywith results fromthehumanraters.The receiver
operating characteristic curves and the area under the curves
(AUC) were calculated using pROC,27 and a comparison of re-
ceiveroperatingcharacteristic curveswasperformedusing the
methodsofDeLongetal.28Theprimaryendpoint for theanaly-
seswasdifference inAUCtodetectskincancerbetweentheCNN
andhumanraters.All reportedPvalueswere from2-sidedtests
and are corrected for multiple testing with the Benjamini-
Hochbergmethod29andareconsideredstatistically significant
at a corrected value of P < .05.
Results
CNN Training and Validation
For thevalidation set, an InceptionV3architecture30 achieved
the highest accuracy rates for dermoscopic images, and a
ResNet50network31had thehighest accuracy for clinical close-
ups.With regard to thedetectionof skin cancer, theAUCof the
CNNwassignificantlyhigherwithdermoscopy thanwithclini-
calclose-ups(0.725;95%CI,0.711-0.725vs0.683;95%CI,0.668-
0.683;P < .001).Regardingspecificdiagnoses, thedermoscopic
CNNwas better at diagnosingmalignant cases, and the close-
up CNN was better at diagnosing benign cases (eTable 3 in
the Supplement). Integration of bothmethods using extreme
gradient boosting achieved significantlyhigher accuracy than
dermoscopyalone (AUC,0.742;95%CI,0.729-0.755;P < .001).
The rate of correct specific diagnoseswas highest in the com-
bined ratings (cCNN, 37.6% vs close-up CNN, 31.1%; P < .001;
and dermoscopic CNN, 36.3%; P = .005).
Comparison of Human RatersWith cCNN
With regard to the detection of skin cancer, the mean AUC of
human raters (0.695; 95% CI, 0.676-0.713) was significantly
lower than themean AUC of the cCNN (0.742; 95% CI, 0.729-
0.755;P < .001) (Figure 1A). Comparing subgroups (Figure 1B),
we found that theCNNhadahigherAUCthandidbeginner rat-
ers (0.749; 95%CI, 0.727-0.771 vs0.655; 95%CI, 0.626-0.684;
P < .001)or the intermediate raters (0.735;95%CI,0.710-0.760;
vs0.690;95%CI,0.657-0.722;P = .02), butnothigher than the
experts (0.733; 95% CI, 0.702-0.765 vs 0.741; 95% CI, 0.719-
0.763; P = .62).
Althoughsensitivitywas77.6%(95%CI, 74.7%-80.5%)and
specificitywas51.3% (95%CI,48.4%-54.3%) forhumanraters,
Table. Summary of Diagnoses in Training and Validation Data Sets
Data Set
Total
No. of
Images
Images, No. (%)
AKIEC Angioma BCC BKL DF Mel Nevus SCC Seb-Ben Trich-Ben
Training
Dermoscopy 7895 1892 (24.0) 26 (0.3) 3855 (48.8) 891 (11.3) 56 (0.7) 58 (0.7) 119 (1.5) 957 (12.1) 18 (0.2) 23 (0.3)
Close-up 5829 1379 (23.7) 16 (0.3) 2832 (48.6) 668 (11.5) 31 (0.5) 37 (0.6) 104 (1.8) 762 (13.1) 0 0
Validation
Dermoscopy 340 8 (2.4) 4 (1.2) 165 (48.5) 41 (12.1) 6 (1.8) 15 (4.4) 7 (2.1) 88 (25.9) 3 (0.9) 3 (0.9)
Close-up 635 16 (2.5) 7 (1.1) 321 (50.6) 80 (12.6) 7 (1.1) 25 (3.9) 10 (1.6) 169 (26.6) 0 0
Abbreviations: AKIEC, actinic keratoses and intraepithelial carcinoma (also known as Bowen disease); BCC, basal cell carcinoma, all subtypes; BKL, benign
keratosis–like lesions including solar lentigo, seborrheic keratosis, and lichen planus–like keratosis; DF, dermatofibroma; Mel, melanoma; SCC, invasive squamous
cell carcinoma and keratoacanthoma; Seb-Ben, benign sebaceous neoplasms; Trich-Ben, benign hair follicle tumors.
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the values for the cCNNwere higher but not significantly dif-
ferent (sensitivity, 80.5%;95%CI, 79.0%-82.1%;P = .12; speci-
ficity, 53.5%; 95%CI, 51.7%-55.3%;P = .298). Except for a sig-
nificantly higher sensitivity of the neural network compared
with beginner raters (81.9%; 95%CI, 79.2%-84.6%; vs 72.3%;
95%CI, 66.7%-77.9%;P = .003), therewereno significant dif-
ferenceswithother subgroupsofhuman raters. Regarding the
rare,but important, classofprimaryamelanoticmelanoma, the
cCNN achieved a sensitivity of 52.3% (95% CI, 47.2%-57.4%)
when diagnosingmalignancy, which was lower than the sen-
sitivity reached by beginner raters (59.8%; 95% CI, 50.6%-
68.5%), intermediate raters (67.8%;95%CI, 58.5%-75.9%), and
expert raters (78.5%; 95% CI, 70.7%-84.7%).
The cCNN, combining analysis of dermoscopy images and
clinicalclose-ups,achievedahigherfrequencyofcorrectspecific
diagnoses (37.6%;95%CI, 36.6%-38.4%) thandidhumanraters
(33.5%;95%CI, 31.5%-35.6%;P = .001).Thisdifferencewassig-
nificant for beginner raters and intermediate raters but not ex-
pertraters(37.3%;95%CI,35.7%-38.8%vs40.0%;95%CI,37.0%-
43.0%;P = .18) (Figure2).With regard tospecificdiagnoses, the
difference between cCNN and human raters was higher when
onlymalignant lesionswereconsidered (55.5%;95%CI,54.0%-
57.1%vs44.9%;95%CI,42.2%-47.7%;P < .001).Whentheanaly-
siswas limited tobenigncases,humanratersweresignificantly
better (frequencyof correct specific diagnoses: 23.4%; 95%CI,
20.8%-25.9%vs 18.1%; 95%CI, 16.8%-19.3%;P = .001). Confu-
sionmatrices(Figure3)demonstratethatthecCNNperformsbet-
teroncommonmalignantclasses(actinickeratosesandintraepi-
thelial carcinoma [Bowen disease], basal cell carcinoma, and
invasivesquamouscellcarcinomaandkeratoacanthoma)butper-
formspoorlyonbenignclassessuchasangiomas,dermatofibro-
mas, nevi, or clear cell acanthomas (Figure 4), which were
underrepresented or absent in the training data.
Discussion
WeshowedthatacCNNisable toclassifynonpigmented lesions
as accurately as expert raters andwith a higher accuracy than
less-experienced raters.Becauseweuseddermoscopic images
andclinical close-ups to train thenetwork,our resultsalsodem-
Figure 1. Comparison of Skin Cancer Detection on Digital Images Between Human Readers and a Neural Network–Based Classifier
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Figure 2. Percentages of Correct Specific Diagnoses of Corresponding
Reading Sets of the Combined Convolutional Neural Network (cCNN)
and Dermatologists Grouped by Experience
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onstratethatacombinationofthe2imagingmodalitiesachieves
better results thaneithermodalityalone. In this regard,wecon-
firmedthe importanceofadding thedermoscopic images to the
clinicalexaminationandtheimportanceofconsideringtheclini-
cal close-up images inaddition to thedermoscopic images and
not to rely on thedermoscopic images alone.32 The2methods
complement each other. The CNN analyzing close-up images
wasmoreaccurate forbenign lesions,whereas theCNNanalyz-
ing the correspondingdermoscopic imageswasmore accurate
formalignant cases (eTable 3 in the Supplement).
Our experimental settingwas artificial anddeviated from
clinical practice in many ways. It was restricted to pure mor-
phologic characteristics, and we did not include important
metadata such as age, anatomic site, and history of the
lesions.Thesedatawill usuallybe readilyavailable to the treat-
ingphysicianandwill affectdiagnosisandmanagement. In this
regard, we see the strength of CNN-based classifiers not so
much inprovidingmanagementdecisions33 but rather in pro-
vidinga listof accuratedifferentialdiagnoses,whichmayserve
as input for other systems that have outputs, such as decision
trees, that are more readily interpretable by humans.
Our data also suffer from verification bias, as only patho-
logically verified cases were selected. This selection leads to
overrepresentationofmalignantcasesandanunequalclassdis-
tribution in the test set,which does not reflect clinical reality.
Dermatopathologic verification, however, is necessary be-
cause the clinical and dermoscopic diagnosis of nonpig-
mented lesions is prone to error, andwe think that the advan-
tageof anaccurate criterion-standarddiagnosis outweighs the
disadvantage of verification bias.
Figure 3. ConfusionMatrices of Specific Diagnoses
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BCC, basal cell carcinoma (all subtypes); BKL, benign keratosis-like lesions
(including solar lentigo, seborrheic keratosis and lichen planus–like keratosis);
DF, dermatofibroma; Mel, melanoma; and SCC, invasive squamous cell
carcinoma.
Figure 4. Example Images
CCA correctly diagnosed by human raters
but incorrectly diagnosed by cCNN
A Intraepithelial carcinoma (Bowen disease) correctly specified
by both the cCNN and all human raters
B
A, A clear cell acanthoma (CCA)
correctly diagnosed by all human
raters, but interpreted as a benign
keratosis-like lesion by the combined
convolutional neural network
(cCNN). Since the class CCAwas not
present in the training data set it is
impossible for the fixed classifier to
ever make that diagnosis. B, An
actinic keratosis and intraepithelial
carcinoma (also known as Bowen
disease) correctly specified by both
the cCNN and all human raters.
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The performance of the cCNN was not uniform across
classes. It outperformed human raters in commonmalignant
classes suchasbasal cell carcinoma,actinickeratosesorBowen
disease, andsquamouscell carcinomaorkeratoacanthomabut
didnotreachtheaccuracyofhumanraters inraremalignantnon-
pigmented lesions such as amelanotic melanoma and benign
nonpigmented lesions. This is a consequence of the relatively
lowfrequencyof thesediseasecategories in the trainingset.Al-
though this, toourknowledge, is the largestdata setofnonpig-
mented dermoscopic images, it still counts as a small data set
in the realm of machine learning with CNNs. During a profes-
sional life, a typical human expert rater has been exposed to a
significantnumberofexemplars,evenfor rarediagnoses,either
through textbooks, e-learning, lectures, or clinical practice.
Therarebut importantclassofamelanoticmelanomaisdif-
ficult to diagnose even for experts. Usually no harm is done if
amelanoticmelanomas aremistaken for othermalignant neo-
plasms or if, in the judgement of the physician, the probability
ofamalignantneoplasmishighenoughtowarrantbiopsyorex-
cision.Dermatoscopy ismoreaccuratewhenclassifyingamela-
noticmelanomaasmalignant rather thanmelanoma.34Assum-
ing that, if the diagnosis of the cCNN is amalignant neoplasm,
the lesionwill bebiopsiedorexcised, thecCNNachieveda sen-
sitivityforamelanoticmelanomaof52.3%(95%CI,47.2%-57.4%),
whichwas lower thantheaveragesensitivityofhumanratersof
69.3%(95%CI,64.5%-73.8%).Wehypothesize that, inaddition
to underrepresentation of amelanoticmelanomas in the train-
ingdata, visual diagnostic clues suchaspolymorphousvessels
are too subtle to be learned from just a few cases. Unless larger
imagecollectionsbecomeavailable,otherdiagnosticdevicessuch
asreflectanceconfocalmicroscopyorautomateddiagnosticsys-
tems that do not depend on morphologic characteristics (eg,
tapestripping,35electrical impedancespectroscopy,36orRaman
spectroscopy)37may be ofmore help in these cases.
Limitations
The loweraccuracyof thepresentedcCNNcomparedwithother
recent publications on automated classification of skin
lesions16,18may be explained in 2ways. One is that our test set
included more than 51 distinct classes, of which most did not
haveenoughexamples tobe integrated into the trainingphase.
Having larger dermoscopy data sets in the future, in the scale
of the number of clinical images that were available to Han
et al,14 may partly resolve this shortcoming. Second, the
features of nonpigmented lesions are less specific than those
of pigmented lesions, which is mirrored by the relatively low
accuracy of human expert raters. Although our cCNN outper-
formed human raters in some aspects, it is currently not fit for
clinical application. The metrics applied to measure diagnos-
tic accuracy, such as sensitivity, specificity, and area under
receiver operating characteristic curves, may not accurately
reflect the performance of a classifier for medical purposes in
all settings. Accurate diagnoses of common diseases such as
basalcell carcinomaandactinickeratoses,whichareusuallynot
life threatening if leftuntreated,mustbecontrastedwithmiss-
ing potentially life-threatening diseases such as amelanotic
melanomas. Althoughmetrics exist that take into account the
potential loss of life-years andapplypenalties tomisdiagnoses
ofmoreaggressivediseases, thesemetricsarecurrentlynotwell
established in the field of machine learning.
Conclusions
Despite limitations, we demonstrated that CNNs can perform
at a human level on the binary classification of pigmented
lesions and on multiclass tasks on more challenging
nonpigmented lesions. The potential of CNNs to solve more
sophisticated classification tasks in dermatology has been
demonstrated before13,14 but not on dermoscopic images of
nonpigmented lesions.Wealso confirm that, similar tohuman
raters,CNNsperformbetterwithdermoscopic images thanwith
clinical close-upsalone.Futureefforts shouldbe targetedat the
availabilityof largernumbersofdermoscopic imagesandclini-
cal close-ups of rare malignant lesions but also of common
benign nonpigmented lesions that are usually not biopsied or
excised for diagnostic reasons. The results of our study sug-
gest that, if more exemplars of these disease categories were
available, it should bepossible to trainCNNs todiagnose these
categories more efficiently.
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